CGRP and migraine: from bench to bedside
Migraine treatment has reached a new era with the development of drugs that target the trigeminal neuropeptide calcitonin gene-related peptide (CGRP) or its receptor. The CGRP related therapies offer considerable improvements over existing drugs as they are the first to be designed to act on the tri...
Saved in:
| Published in: | Revue neurologique Vol. 177; no. 7; pp. 785 - 790 |
|---|---|
| Main Author: | |
| Format: | Journal Article |
| Language: | English |
| Published: |
France
Elsevier Masson SAS
01.09.2021
|
| Subjects: | |
| ISSN: | 0035-3787 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!